What follows covers the three primary injection sites in detail, the science behind absorption differences between sites, step-by-step injection technique, a complete rotation schedule you can follow week by week, troubleshooting for common injection site problems, and the specific considerations that make retatrutide administration different from other GLP-1 receptor agonists
Both conditions can cause abdominal distension, cramping, severe constipation, nausea, vomiting, dehydration, and inability to pass gas or stool
They were also a big part of why the dose is raised gradually: starting low and going slow meaningfully reduced how many people experienced them
It does not correspond to a fourth biological receptor
By Lana Pine | Published on June 19, 2025 4 min read People with diabetes who take glucagon-like peptide-1 (GLP-1) receptor agonists (such as Ozempic and Wegovy) may have more than twice the risk of developing a serious eye condition called neovascular age-related macular degeneration (nAMD) a leading cause of vision loss in older adults according to a large-scale study published in JAMA Ophthalmology